Literature DB >> 8115810

Experimental pulmonary schistosomiasis: lack of morphological evidence of modulation in schistosomal pulmonary granulomas.

M R Vidal1, A A Barbosa Júnior, Z A Andrade.   

Abstract

Numerous pulmonary schistosome egg granulomas were present in mice submitted to partial portal vein ligation (Warren's model). The granulomas were characterized by cellular aggregations formed within alveolar tissue. Main cellular types were macrophages (epithelioid cells), eosinophils, plasma cells and lymphocytes. These cells were supported by scanty fibrous stroma and exhibited close membrane contact points amongst themselves, but without forming specialized adhesion apparatus. When granulomas involved arterial structures, proliferation of endothelial and smooth muscle cells occurred and fibrosis associated with angiogenesis became more evident. Granulomas formed around mature eggs in the pulmonary alveolar tissue presented approximately the same size and morphology regardless of the time of infection, the latter being 10, 18 and 25 weeks after cercarial exposure. This persistence of morphological appearance suggests that pulmonary granulomas do not undergo immunological modulation, as is the case with the granulomas in the liver and, to a lesser extent, in the intestines. Probably, besides general immunological factors, local (stromal) factors play an important role in schistosomal granuloma modulation.

Entities:  

Mesh:

Year:  1993        PMID: 8115810     DOI: 10.1590/s0036-46651993000500007

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  2 in total

1.  Trichobilharzia szidati: the lung phase of migration within avian and mammalian hosts.

Authors:  M Chanová; S Vuong; P Horák
Journal:  Parasitol Res       Date:  2006-12-20       Impact factor: 2.289

Review 2.  Schistosomes in the Lung: Immunobiology and Opportunity.

Authors:  Emma L Houlder; Alice H Costain; Peter C Cook; Andrew S MacDonald
Journal:  Front Immunol       Date:  2021-04-19       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.